Anhydrosafflor Yellow B alleviates brain injury of acute permanent cerebral ischemia in rats by anti-inflammatory mechanism

References

• Buchanan MM, Hutchinson M, Watkins LR, Yin H. 2010. Toll-like receptor 4 in CNS pathologies. J Neurochem. 114:13–27.
   PubMed Web of Science ®Google Scholar
• Chen S, Sun M, Zhao XH, Yang ZF, Liu WX, Cao JY. 2019. Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis. Mol Med Rep. 19:3009–3020.
   PubMed Web of Science ®Google Scholar
• Durand JK, Baldwin AS. 2017. Targeting IKK and NF-κB for therapy. Adv Protein Chem Struct Biol. 107:77–115. doi: https://doi.org/10.1016/bs.apcsb.2016.11.006
   PubMed Web of Science ®Google Scholar
• Famakin BM. 2014. The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review. Aging Dis. 5:307–326.
   PubMed Web of Science ®Google Scholar
• Fisher M, Saver JL. 2015. Future directions of acute ischaemic stroke therapy. Lancet Neurol. 14:758–767. doi: https://doi.org/10.1016/S1474-4422(15)00054-X
   PubMed Web of Science ®Google Scholar
• Griffiths MR, Gasque P, Neal JW. 2009. The multiple roles of the innate immune AHSYB stem in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol. 68:217–226. doi: https://doi.org/10.1097/NEN.0b013e3181996688
   Google Scholar
• Hua F, Ma J, Ha T, Kelley JL, Kao RL, Schweitzer JB. 2009. Differential roles of TLR2 and TLR-4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res. 1262:100–108. doi: https://doi.org/10.1016/j.brainres.2009.01.018
   PubMed Web of Science ®Google Scholar
• Hua F, Tang HL, Wang J, Megan CP, Hua XD, Donald GS. 2015. TAK-242, an antagonist for toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J Cerebral Blood Flow Metab. 2:1–7.
   Google Scholar
• Jiang W, Li GL. 2017. Neurology, clinical study on Safflower injection combined with cilostazol in treatment of acute ischemic cerebral infarction. Drugs and Clinic. 32:617–620.
   Google Scholar
• Jin M, Sun CY, Pei CQ, Wang L, Zhang PC. 2013. Effect of safflor yellow injection on inhibiting lipopolysaccharide induced pulmonary infammatory injury in mice. Chin J Integrat Med. 19:836–843. doi: https://doi.org/10.1007/s11655-012-1151-6
   Google Scholar
• Jordi R, Monica G, Christian S, Katerina A, Annelies SZ, Victor N, Randall SJ, Gabriel GH, Karin M. 2008. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature. 453:807–811. doi: https://doi.org/10.1038/nature06905
   Google Scholar
• Josef A, Costantino I. 2016. Inflammation and stroke: an overview. Neurotherapeutics. 13:661–670. doi: https://doi.org/10.1007/s13311-016-0483-x
   Google Scholar
• Lehnardt S. 2008. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci. 28:2320–2331. doi: https://doi.org/10.1523/JNEUROSCI.4760-07.2008
   PubMed Web of Science ®Google Scholar
• Li Y. 2011. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and toll-like receptor 4. J Biol Chem. 286:31308–31319. doi: https://doi.org/10.1074/jbc.M111.246124
   PubMed Web of Science ®Google Scholar
• Li F, Run P, Zhao HY, Liu X, Ma C, Wang BR. 2011. Stability and degradation of hydroxysafflor yellow A and anhydrosafflor yellow B in the safflower injection studied by HPLC-DAD-ESI­­-MS. J Chin Pharmaceut Sci. 20:47–56.
   Google Scholar
• Mahban R, Faheem M, Shermineh M, Kamal N, Mohammad A, Nady B, Seyed MN, Seyed FN. 2017. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev. 36:11–19. doi: https://doi.org/10.1016/j.arr.2017.02.004
   Google Scholar
• Minami M, Katayama T, Satoh M. 2006. Brain cytokines and chemokines: roles in ischemic injury and pain. J Pharmacol Sci. 100:461–470. doi: https://doi.org/10.1254/jphs.CRJ06005X
   PubMedGoogle Scholar
• Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ. 2016. Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation. 133:447–454. doi: https://doi.org/10.1161/CIR.0000000000000366
   PubMed Web of Science ®Google Scholar
• Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. 2016. Inflammatory disequilibrium in stroke. Circ Res. 119:142–158. doi: https://doi.org/10.1161/CIRCRESAHA.116.308022
   PubMed Web of Science ®Google Scholar
• Qu C, Wang LY, Jin WT. 2016. Comparative analysis of the effects of hydroxysafor yellow A and anhydrosafor yellow B in safflower series of herb pairs using prep-HPLC and a selective knock-out approach. Molecules. 21:1480. doi: https://doi.org/10.3390/molecules21111480
   Google Scholar
• Sibani S, Dipankar C, Arijit B, Mrinal KG. 2019. Cerebral ischemic stroke: cellular fate and therapeutic opportunities. Front Biosci. 24:435–450. doi: https://doi.org/10.2741/4727
   Google Scholar
• Simone V, Arturo C, Marco A, Domenico C. 2017. Postischemic inflammation in acute stroke. J Clin Neurol. 13:1–9. doi: https://doi.org/10.3988/jcn.2017.13.1.1
   Google Scholar
• Song LJ, Zhu Y, Jin M, Zang BX. 2013. Hydroxysafflflor yellow A inhibits lipopolysaccharide-induced inflflammatory signal transduction in human alveolar epithelial A549 cells. Fitoterapia. 84:107–114. doi: https://doi.org/10.1016/j.fitote.2012.11.004
   PubMed Web of Science ®Google Scholar
• Sun L, Yang L, Xu YW, Liang H, Han J, Zhao RJ. 2012. Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: Inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption. Brain Res. 1473:227–235. doi: https://doi.org/10.1016/j.brainres.2012.07.047
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Triantafilou K. 2004. Heat-shock protein 70 and heat-shock protein 90 associate with toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem Soc Trans. 32:636–639. doi: https://doi.org/10.1042/BST0320636
   PubMed Web of Science ®Google Scholar
• Tsan MF, Gao B. 2004. Endogenous ligands of toll-like receptors. J Leukoc Biol. 76:514–519. doi: https://doi.org/10.1189/jlb.0304127
   PubMed Web of Science ®Google Scholar
• Zea LE, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. doi: https://doi.org/10.1161/01.STR.20.1.84
   PubMed Web of Science ®Google Scholar
• Zhang HL, Gu ZL, Savitz SI, Han F, Fukunaga K, Qin ZH. 2008. Neuroprotective effects of prostaglandin A1 in rat models of permanent focal cerebral ischemia are associated with nuclear factor-κB inhibition and peroxisome proliferator activated receptor-up-regulation. J Neurosci Res. 86:1132–1141. doi: https://doi.org/10.1002/jnr.21569
   Google Scholar